Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis-Reference-Cited by-同舟云学术

Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis

Published:2005-09-08 Issue:5 Volume:118 Page:1215-1226
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Wu Jian-Yu,Vlastos Anne-Therese,Pelte Marie-Françoise,Caligo Maria-Adelaide,Bianco Andrea,Krause Karl-Heinz,Laurent Geoffrey J.,Irminger-Finger Irmgard

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference53 articles.

1. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival;Jemal;Cancer,2004

2. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy;Sugiyama;Cancer,2000

3. Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas;Faleiro-Rodrigues;Ann Oncol,2004

4. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer;Bali;Clin Cancer Res,2004

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer;Translational Oncology;2024-06

2. A genome-wide association study reveals the relationship between human genetic variation and the nasal microbiome;Communications Biology;2024-01-30

3. A genome-wide association study reveals human genetic impact on the nasal microbial diversity, taxa and functions;2023-07-12

4. The Fundamental Role of BARD1 Mutations and Their Applications as a Prognostic Biomarker for Cancer Treatment;BRCA1 and BRCA2 Mutations - Diagnostic and Therapeutic Implications;2023-01-18

5. BARD1 mystery: tumor suppressors are cancer susceptibility genes;BMC Cancer;2022-06-01